Stay updated on SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial
Sign up to get notified when there's something new on the SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial page.

Latest updates to the SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page shows an updated revision label, changing from v3.5.2 to v3.5.3. This reflects a new site release without altering the study details or layout.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision note updated to v3.5.2, replacing v3.5.0 on the page.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 on the page.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed, indicating a metadata version update that does not alter study details or displayed information.SummaryDifference0.0%

- Check90 days agoChange DetectedRevision: v3.4.2 was added; the funding-status notice and Revision: v3.4.1 were removed. These updates are administrative and do not affect the study details on the page.SummaryDifference0.3%

- Check97 days agoChange DetectedA site-wide notice about a lapse in government funding was added, and the page shows Revision: v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial page.